With a high population density and over 45% of the global breast cancer incidence, Asia is expected to account for more than half of all TNBC cases, with a large TNBC patient pool, particularly in China and India.

其他相關內容

2025/12/18 文章

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

...

報告